RecruitingNot ApplicableNCT05428228

Clinical Study to Evaluate the Effects of Two Novel Hydration Beverage Formulas on Rehydration in Healthy Adults

A Randomized, Placebo Controlled, Semi-Blind, Crossover Study to Evaluate the Effects of Two Novel Hydration Beverage Formulas on Rehydration in Healthy Adults


Sponsor

Liquid I.V.

Enrollment

16 participants

Start Date

Oct 1, 2022

Study Type

INTERVENTIONAL

Conditions

Summary

The aim of the clinical trial is to evaluate the efficacy of two novel hydration products on rehydration following exercise.


Eligibility

Min Age: 18 YearsMax Age: 35 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Placebo, TP1, and others for people with cognitive performance, dehydration, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 35 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERTP1

Participants will be administered TP1 during one of the experimental visits.

OTHERTP2

Participants will be administered TP2 during one of the experimental visits.

OTHERPlacebo

Participants will be administered placebo during one of the experimental visits.


Locations(1)

The University of Memphis

Memphis, Tennessee, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05428228


Related Trials